Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06390332 · ClinicalTrials.gov registry record · NA

Centering Gender Affirming Resources in Higher Education

A NA study of Sexual Violence and Drinking Heavy, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06390332: Recruiting NA study of Sexual Violence and Drinking Heavy, sponsored by University of Pittsburgh.

NCT06390332 is a NA study of Sexual Violence and Drinking Heavy that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 100 participants, below the 811-participant average among 10 other Sexual Violence trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06390332, a NA study of Sexual Violence and Drinking Heavy, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Centering gender Affirming Resources in higher Education (CARE) project is nested within the parent study "Reducing Alcohol Involved Sexual violence in higher Education" (RAISE; R01 AA023260; NCT05185440). CARE is a pilot cluster-randomized trial that centers trans and gender diverse (TGD) students who are at elevated risk for SV and hazardous drinking. CARE tests a novel college health and counseling center (CHC) training program designed to improve provider knowledge about TGD individuals, increase their self-efficacy and use of trans-inclusive practices. This includes an evaluation of the feasibility, acceptability, appropriateness, and usability of CARE's training intervention for college health and counseling center providers. This research will produce the first rigorously evaluated TGD-focused CHC provider training which has the potential to increase the accessibility of CHC's for TGD university students- ultimately lowering rates of alcohol use and SV among this disproportionately impacted population.

Primary Outcome

Domain: Provider-Perceived Feasibility Specific Measurement: Feasibility of Intervention Measure (FIM). Specific Metric: End value Method of Aggregation: Mean score, range 1-5 cutoff mean score \> 4, higher score indicates greater feasibility

Interventions

  • BEHAVIORAL Giving Information for Trauma Support and Safety (GIFTSS) Training
  • BEHAVIORAL Centering gender Affirming Resources in higher Education (CARE) Learning Modules

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-12-11
Est. Completion 2027-05
Phase NA
University of Pittsburgh

1,238 total trials

What NCT06390332 shows while recruiting

NCT06390332 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 811-participant average among 10 other Sexual Violence trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Sexual Violence appearing as the primary indexed condition, and to 2 interventions - of which Giving Information for Trauma Support and Safety (GIFTSS) Training is the first listed.

NCT06390332 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06390332 about?

NCT06390332 is a clinical study titled "Centering Gender Affirming Resources in Higher Education". Centering gender Affirming Resources in higher Education (CARE) project is nested within the parent study "Reducing Alcohol Involved Sexual violence in higher Education" (RAISE; R01 AA023260; NCT05185440). CARE is a pilot cluster-randomized trial that centers trans and gender diverse (TGD) students ...

What is the current status of trial NCT06390332?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-12-11. Estimated completion is 2027-05.

What conditions does trial NCT06390332 study?

This clinical trial studies the following conditions: Sexual Violence, Drinking Heavy.

What interventions are being tested in trial NCT06390332?

The interventions under investigation include: Giving Information for Trauma Support and Safety (GIFTSS) Training (BEHAVIORAL), Centering gender Affirming Resources in higher Education (CARE) Learning Modules (BEHAVIORAL).

Who is sponsoring clinical trial NCT06390332?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06390332 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sexual Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06390332's enrollment target sits among peer trials

100 9th of 10 higher than 2 of 10 other Sexual Violence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sexual Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06390332, the US trial registry maintained by the National Library of Medicine. NCT06390332 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.